Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes
F Petrelli, F Trevisan, M Cabiddu, G Sgroi… - Annals of …, 2020 - journals.lww.com
Background: The addition of induction chemotherapy to concomitant neoadjuvant
chemoradiation in locally advanced rectal cancer could increase pathological downstaging …
chemoradiation in locally advanced rectal cancer could increase pathological downstaging …
[HTML][HTML] Impact of Sarcopenia on Treatment Outcomes and Toxicity in Locally Advanced Rectal Cancer
Background and Objectives: Sarcopenia, a condition characterized by muscle mass loss, is
prevalent in up to 68% of rectal cancer patients and has been described as a negative …
prevalent in up to 68% of rectal cancer patients and has been described as a negative …
[HTML][HTML] Diagnosis of Relapse of Colorectal Adenocarcinoma through CEA Fluctuation
Carcinoembryonic antigen (CEA) is a routine marker employed for follow-up of colorectal
tumors. We aimed to determine whether a CEA increase within the normal range can be …
tumors. We aimed to determine whether a CEA increase within the normal range can be …
Neoadyuvancia en cáncer de recto. Protocolo de valoración anatomopatológica de la respuesta
MT González-Nicolás Trébol… - zaguan.unizar.es
Objetivo: La valoración anatomopatológica de la respuesta tumoral a la quimiorradioterapia
neoadyuvante. Métodos: Se seleccionaron retrospectivamente los pacientes del HCU …
neoadyuvante. Métodos: Se seleccionaron retrospectivamente los pacientes del HCU …